Company Overview of Thios Pharmaceuticals, Inc.
Thios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule and antibody therapeutics. Its small molecule and antibody therapeutics targets on sulfation pathways, which regulate cell adhesion and cell migration, growth factor mobilization, or neo-vascularization. The company develops monoclonal antibody and small molecule candidates for the treatment of chronic inflammation, cancer, and infectious diseases. Thios Pharmaceuticals was founded in 2000 and is based in Emeryville, California.
5980 Horton Street
Emeryville, CA 94608
Founded in 2000
Key Executives for Thios Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Eniva Corporation||United States|
|Expression Genetics, Inc.||United States|
|Akorn Ophthalmics, Inc.||United States|
|Raland Therapeutics, Inc.||United States|
|New Century Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Chapel Hill, NC | Cempra PharmaceuticalsPosted: Jun 11
- Connecticut | Boehringer IngelheimPosted: May 27
- Bakersfield, CA | AstraZenecaPosted: Jun 17
- Field, KY | Shire PharmaceuticalsPosted: May 26
Sponsored Financial Commentaries
To contact Thios Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.